Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 12/20 | 0.54 |
| ▸ | P2RY4 | P51582 | 8/20 | 0.54 |
| ▸ | P2RY6 | Q15077 | 11/20 | 0.51 |
| ▸ | POLA1 | P09884 | 1/20 | 0.50 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyanide SCHEMBL29185226 | 0.97 | P2RY2 (0.51) | P2RY2P2RY4P2RY6POLA1P2RY14 | |
| SCHEMBL8437049 | 0.90 | P2RY2 (0.53) | P2RY2P2RY4P2RY6POLA1P2RY14 | |
| SCHEMBL8440653 | 0.89 | P2RY2 (0.54) | P2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL31381447 | 0.87 | P2RY14 (0.56) | P2RY2P2RY4P2RY6POLA1P2RY14 | |
| SCHEMBL8437841 | 0.87 | P2RY2 (0.59) | P2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL8439076 | 0.85 | P2RY2 (0.55) | P2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL6694199 | 0.84 | P2RY6 (0.54) | P2RY2P2RY4P2RY6POLA1P2RY14 | |
| SCHEMBL95680 | 0.84 | P2RY6 (0.54) | P2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL3635669 | 0.84 | POLG (0.46) | P2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL5144406 | 0.84 | P2RY2 (0.55) | P2RY2P2RY4P2RY6POLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636304-B2 | — | — | 2026-05-26 | — | — | US | disclosed |
| US-20240384261-A1 | METHODS, COMPOSITIONS, AND KITS FOR PREPARING SEQUENCING LIBRARY | GENEFIRST LIMITED (GB) | 2024-11-21 | — | — | US | disclosed |
| US-20240350621-A1 | DOUBLE STRANDED MRNA VACCINES | UNIV IOWA RES FOUND (US) | 2024-10-24 | — | — | US | disclosed |
| CN-117795096-A | Methods, compositions and kits for preparing sequencing libraries | 吉复生物科技有限公司 | 2024-03-29 | — | — | CN | disclosed |
| WO-2023014974-A1 | DOUBLE STRANDED MRNA VACCINES | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2023-02-09 | — | — | WO | disclosed |
| CN-115667502-A | Modified macrophages, compositions thereof and uses thereof | 通用干细胞股份有限公司 | 2023-01-31 | — | — | CN | disclosed |
| WO-2022263807-A1 | METHODS, COMPOSITIONS, AND KITS FOR PREPARING SEQUENCING LIBRARY | GENEFIRST LIMITED (GB) | 2022-12-22 | — | — | WO | disclosed |
| US-10550422-B2 | Methods and compositions for labeling nucleic acids | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2020-02-04 | — | — | US | disclosed |
| EP-1937849-B1 | METHODS AND COMPOSITIONS FOR LABELING NUCLEIC ACIDS | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-05-29 | — | — | EP | disclosed |
| EP-1937850-B1 | METHODS AND COMPOSITIONS FOR LABELING NUCLEIC ACIDS | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-05-29 | — | — | EP | disclosed |
| US-7910335-B2 | Methods and compositions for labeling nucleic acids | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2011-03-22 | — | — | US | disclosed |
| US-20110065907-A1 | Methods and compositions for labeling nucleic acids | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2011-03-17 | — | — | US | disclosed |
| US-20100311063-A1 | METHODS AND COMPOSITIONS FOR LABELING NUCLEIC ACIDS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2010-12-09 | — | — | US | disclosed |
| US-7767421-B2 | Tagging nucleotide sequences with nucleoside analogue that comprises azide group reacted with substituted triarylphosphine; enhancing disease diagnosis and accuracy of toxicity bioassays | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-08-03 | — | — | US | disclosed |
| EP-1937850-A2 | METHODS AND COMPOSITIONS FOR LABELING NUCLEIC ACIDS | The President and Fellows of Harvard College (US) | 2008-07-02 | — | — | EP | disclosed |
| EP-1937849-A2 | METHODS AND COMPOSITIONS FOR LABELING NUCLEIC ACIDS | The President and Fellows of Harvard College (US) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007120192-A2 | METHODS AND COMPOSITIONS FOR LABELING NUCLEIC ACIDS | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-10-25 | — | — | WO | disclosed |
| US-20070207476-A1 | Methods and compositions for labeling nucleic acids | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-09-06 | — | — | US | disclosed |
| WO-2007050811-A2 | METHODS AND COMPOSITIONS FOR LABELING NUCLEIC ACIDS | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-05-03 | — | — | WO | disclosed |
| US-20070099222-A1 | Tagging nucleotide sequences with nucleoside analogue that comprises azide group reacted with substituted triarylphosphine; enhancing disease diagnosis and accuracy of toxicity bioassays | Life Technologies Corporation | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12636304-B2 | — | RNMT, RNGTT, NSUN2 | P2RY2 2861/4885P2RY4 3525/4885P2RY6 2908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.